Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease von Moe, Alison, Rayasam, Aditya, Sauber, Garrett, Shah, Ravi K, Doherty, Ashley, Yuan, Cheng-Yin, Szabo, Aniko, Moore, 2nd, Bob M, Colonna, Marco, Cui, Weiguo, Romero, Julian, Zamora, Anthony E, Hillard, Cecilia J, Drobyski, William R

Volltext

Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189 von Reiner, Anton, Heldt, Scott A, Presley, Chaela S, Guley, Natalie H, Elberger, Andrea J, Deng, Yunping, D'Surney, Lauren, Rogers, Joshua T, Ferrell, Jessica, Bu, Wei, Del Mar, Nobel, Honig, Marcia G, Gurley, Steven N, Moore, 2nd, Bob M

Volltext

Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics von Yu, Ying, Li, Lexiao, Nguyen, Davis T., Mustafa, Suni M., Moore, Bob M., Jiang, Jianxiong

Volltext

Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts von Abidi, Ammaar H., Presley, Chaela S., Dabbous, Mustafa, Tipton, David A., Mustafa, Suni M., Moore, Bob M.

Volltext

Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist von Bu, Wei, Ren, Huiling, Deng, Yunping, Del Mar, Nobel, Guley, Natalie M, Moore, Bob M, Honig, Marcia G, Reiner, Anton

Volltext

Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury von Pressly, Jeffrey D, Mustafa, Suni M, Adibi, Ammaar H, Alghamdi, Sahar, Pandey, Pankaj, Roy, Kuldeep K, Doerksen, Robert J, Moore, Jr, Bob M, Park, Frank

Volltext

Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Expe... von Kiran, Sonia, Rakib, Ahmed, Moore, Bob M, Singh, Udai P

Volltext

Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system von Presley, Chaela S., Abidi, Ammaar H., Moore, Bob M.

Volltext

Raloxifene Modulates Microglia and Rescues Visual Deficits and Pathology After Impact Traumatic Brain Injury von Honig, Marcia G., Del Mar, Nobel A., Henderson, Desmond L., O’Neal, Dylan, Doty, John B., Cox, Rachel, Li, Chunyan, Perry, Aaron M., Moore, Bob M., Reiner, Anton

Volltext

Synthesis and biological evaluation of (3′,5′-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist von Presley, Chaela S., Mustafa, Suni M., Abidi, Ammaar H., Moore, Bob M.

Volltext

DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity von Hama, Taketsugu, Nagesh, Prashanth Kb, Chowdhury, Pallabita, Moore, 2nd, Bob M, Yallapu, Murali M, Regner, Kevin R, Park, Frank

Volltext

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice von Parks, Cory, Rogers, Chris M., Prins, Pjotr, Williams, Robert W., Chen, Hao, Jones, Byron C., Moore, Bob M., Mulligan, Megan K.

Volltext

Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189 von Alghamdi, Sahar S., Mustafa, Suni M., Moore II, Bob M.

Volltext

Comparison and Functional Genetic Analysis of Striatal Protein Expression Among Diverse Inbred Mouse Strains von Parks, Cory, Giorgianni, Francesco, Jones, Byron C, Beranova-Giorgianni, Sarka, Moore Ii, Bob M, Mulligan, Megan K

Volltext

Raloxifene Mitigates Emotional Deficits after Mild Traumatic Brain Injury in Mice von Honig, Marcia G, Del Mar, Nobel A, Moore, Bob M, Reiner, Anton

Volltext

Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233 von Gurley, Steven N., Abidi, Ammaar H., Allison, Patrick, Guan, Peihong, Duntsch, Christopher, Robertson, Jon H., Kosanke, Stanley D., Keir, Stephen T., Bigner, Darell D., Elberger, Andrea J., Moore, Bob M.

Volltext

Corrigendum to ‘Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system’ [Analytical Biochemistry 498 (2016) 8–28] von Presley, Chaela S., Abidi, Ammaar H., Moore, Bob M.

Volltext

Preclinical evaluation of SMM‐189, a cannabinoid receptor 2‐specific inverse agonist von Presley, Chaela, Abidi, Ammaar, Suryawanshi, Satyendra, Mustafa, Suni, Meibohm, Bernd, Moore, Bob M.

Volltext

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy von Joers, Valerie, Murray, Benjamin C, McLaughlin, Caroline, Oliver, Danielle, Staley, Hannah E, Coronado, Jazmyn, Achat-Mendes, Cindy, Golshani, Sanam, Kelly, Sean D, Goodson, Matthew, Lee, Danica, Manfredsson, Fredric P, Moore Ii, Bob M, Tansey, Malú Gámez

Volltext

Quantitative structure–activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations von Ferreira, Antonio M., Krishnamurthy, Mathangi, Moore, Bob M., Finkelstein, David, Bashford, Donald

Volltext